What does Mainz Biomed NV do?

Jun 22 2025 07:16 PM IST
share
Share Via
Mainz Biomed NV is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $5 million as of December 2023, with a market cap of $6.03 million. Key financial metrics indicate it is loss-making, with a return on equity of -319.55% and no dividend yield.
Overview:
Mainz Biomed NV operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 0 Million (Quarterly Results - Dec 2023)
Most recent Net Profit: -5 Million (Quarterly Results - Dec 2023)
Market cap: USD 6.03 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.58
Return on Equity: -319.55%
Price to Book: 1.00

Contact Details:
Details: No Company Details Available
Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Mainz Biomed NV technically bullish or bearish?
Jun 25 2025 09:16 AM IST
share
Share Via
How big is Mainz Biomed NV?
Jun 22 2025 06:26 PM IST
share
Share Via